CompletedPHASE1, PHASE2NCT01425528
Study of Kuvan Treatment in Adults With GTPCH Deficiency
Studying GTP cyclohydrolase I deficiency
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- University of Utah
- Principal Investigator
- Kathryn J Swoboda, MDUniversity of Utah
- Intervention
- Sapropterin(drug)
- Enrollment
- 12 target
- Eligibility
- 18 years · All sexes
- Timeline
- 2011 – 2013
Study locations (1)
- University of Utah, Salt Lake City, Utah, United States
Collaborators
BioMarin Pharmaceutical
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT01425528 on ClinicalTrials.gov